Press Releases

Recently Chinese leading human resource media company HRoot announced its "2023 HRoot Awards in Greater China". Hansoh Pharma was once again honored w...

The IASLC 2023 World Conference on Lung Cancer (WCLC) is scheduled to be held in Singapore from September 9 - 12, 2023. During this conference, Hansoh...

Recently, the China National Intellectual Property Administration issued its Decision on the Awarding of the 24th China Patent Award. The invention pa...

Shanghai ,July 20, 2023 – Hansoh Pharma(03692.HK）, a leading innovation-driven pharmaceutical company in Greater China, today announced that China’s N...

On June 30, Hansoh Pharma's Saint Luolai(Pegmolesatide Injection) ,the global unique once-monthly peptide-based highly specific EPO receptor activator...

Recently, Hansoh Pharma was included in the first “Sustainability Yearbook (China)” published by S&P Global, ranking in the Top 1% for its S&P Global ...

Recently, the internationally renowned pharmacology journal — Frontiers in Pharmacology — published an online clinical study paper on Fulaimei® (PEG-L...

Recently, the "2023 China Brand Value Evaluation Information" was released by Xinhua News Agency in conjunction with the China Brand Building Promotio...